Skip to main content
. 2022 Nov 22;35:10772. doi: 10.3389/ti.2022.10772

FIGURE 1.

FIGURE 1

Study design. BM, bone marrow; w, week; d, day; KTx, kidney transplant; SOC, standard of care treatment (including plasmapheresis 7x, intravenous immunoglobulins 100 mg/kg 7x, and corticosteroids); MSC, mesenchymal stem cell therapy; eGFR CKD EPI, estimated glomerular filtration rate according to the Chronic Kidney Disease Epidemiology Collaboration formula; ECC, excreted creatinine clearance; US, ultrasound; UPCR, urinary protein:creatinine ratio; HLA, human leukocyte antigen; DSA, donor specific antibodies; ATR1, antibodies against angiotensin receptor type 1; ETAR, antibodies against endothelin-1 type A receptor; miRNA, microRNA expression.